Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2012
03/14/2012CN101491573B Plant extract for treating rheumatoid arthritis
03/14/2012CN101318011B Pentapeptide nose spraying agent for thymus gland, preparation method and application thereof
03/14/2012CN101284016B Bezoar vitro bred and solid oral preparation containing the bezoar
03/13/2012US8133972 IgE antigenic peptides
03/13/2012US8133885 Non steroidal glucocorticoid receptor modulators
03/13/2012US8133877 Composition comprising an antisense sequence implicated in the regulation of angiogenesis
03/13/2012US8133728 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/13/2012US8133726 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/13/2012CA2676670C Tricyclic compounds, compositions, and methods
03/13/2012CA2643097C Amine derivatives
03/13/2012CA2587791C Method for treating neuropathic pain and associated syndromes
03/13/2012CA2548379C Compositions of galactomannan for the treatment of bowel diseases
03/13/2012CA2521254C Formulations for mediating inflammation and for reducing blood cholesterol
03/13/2012CA2515574C Aminophosphonic acid derivative, salt thereof, and modulator of s1p receptor
03/13/2012CA2442854C Hsa-free formulations of interferon-beta
03/13/2012CA2402191C Use of insulin for the treatment of cartilagenous disorders
03/13/2012CA2369074C Ether compounds, compositions, and uses thereof
03/13/2012CA2365898C Ibd-associated microbial antigens and methods of using same
03/13/2012CA2356779C Cytokine receptor chain
03/08/2012WO2012031296A2 Methods and composition for inhibiting or attenuating leukocyte-endothelial interactions
03/08/2012WO2012031252A1 High dose buprenorphine compositions and use as analgesic
03/08/2012WO2012031220A2 Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use
03/08/2012WO2012031057A1 Bms- 582949 for the treatment of resistant rheumatic disease
03/08/2012WO2012030948A1 Quinazoline compounds and methods of use thereof
03/08/2012WO2012030907A1 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
03/08/2012WO2012030894A1 Thienopyridine and thienopyrimidine compounds and methods of use thereof
03/08/2012WO2012030745A1 MULTIVITAMIN TARGETING OF RNAi THERAPEUTICS
03/08/2012WO2012030170A2 Novel compound acting as a cannabinoid receptor-1 inhibitor
03/08/2012WO2012030137A2 Pharmaceutical composition for preventing or treating inflammatory diseases, allergic diseases or asthma, containing diospyros blancoi a. dc. extract as active ingredient
03/08/2012WO2012029529A1 Eggshell membrane solubilization method using enzymes
03/08/2012WO2012029097A1 Transdermal preparation
03/08/2012WO2012028331A1 Substituted tetrahydropyrrolopyrazine derivatives
03/08/2012WO2012027965A1 Novel compounds
03/08/2012WO2012012300A3 Treatment of the adverse side-effects associated with administration of an anti-hyaluronan agent
03/08/2012WO2012003912A8 Bipyridyl derivatives useful for the treatment of kinase - induced diseases
03/08/2012WO2012002986A3 Decellularized and delipidized extracellular matrix and methods of use
03/08/2012WO2011139765A3 Compounds that modulate intracellular calcium
03/08/2012WO2011130740A3 Pyridylthiazole-based ureas as inhibitors of rho associated protein kinase (rock) and methods of use
03/08/2012WO2011119011A9 Lipid emulsion having krill oil as an active ingredient and preparation method therefor
03/08/2012WO2010129864A9 Methods and compositions for studying, imaging, and treating pain
03/08/2012WO2010124121A8 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
03/08/2012US20120060230 Methods and compositions for modification of a hla locus
03/08/2012US20120059358 Dna vaccines encoding heat shock proteins
03/08/2012US20120059176 Anti-inflammatory modalities
03/08/2012US20120059067 1-acetyl-5-hydroxyanthracene-9,10-dione for treatment of retinal disease
03/08/2012US20120059066 Pharmaceutical salts
03/08/2012US20120059055 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
03/08/2012US20120059046 Inhibition of map4k4 through rnai
03/08/2012US20120059037 Substituted pyridine derivatives and their medical use
03/08/2012US20120059029 Selective integrin inhibitors
03/08/2012US20120059016 Piperidine and piperazine derivatives as autotaxin inhibitors
03/08/2012US20120059006 Sigma receptor inhibitors
03/08/2012US20120059002 Novel anti-inflammatory agents
03/08/2012US20120059001 Novel kinase modulators
03/08/2012US20120059000 Chemical compounds, compositions and methods for kinase modulation
03/08/2012US20120058999 Substituted Tetrahydropyrrolopyrazine Compounds
03/08/2012US20120058998 Compounds, Compositions and Methods for the Treatment of Inflammatory Diseases
03/08/2012US20120058997 Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
03/08/2012US20120058994 Novel compounds
03/08/2012US20120058986 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
03/08/2012US20120058984 Pyrimidine derivatives used as itk inhibitors
03/08/2012US20120058972 Novel use
03/08/2012US20120058968 Composition containing fermantable polysaccharides
03/08/2012US20120058966 Sphingosine Kinase Inhibitor Prodrugs
03/08/2012US20120058963 Macrolides with Anti-Inflammatory Activity
03/08/2012US20120058958 Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
03/08/2012US20120058950 Detection of neuropeptides associated with pelvic pain disorders and uses thereof
03/08/2012US20120058948 Collagen peptides as immune modulators
03/08/2012US20120058936 Compositions and methods for elimination of gram negative bacteria
03/08/2012US20120058211 Defined dose therapeutic phage
03/08/2012US20120058205 Compositions and treatment regimes for reducing inflammation, end-organ injury, and/or systemic endotoxemia
03/08/2012US20120058199 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
03/08/2012US20120058160 Particulate materials
03/08/2012US20120058137 Efficient transport into white blood cells
03/08/2012US20120058133 Inhibition of trna synthetases and therapeutic applications thereof
03/08/2012US20120058128 Anti- integrin antibodies, compositions, methods and uses
03/08/2012US20120058125 Methods relating to peripheral administration of nogo receptor polypeptides
03/08/2012US20120058119 Human tumor necrosis factor tr21 and methods based thereon
03/08/2012US20120058110 Method for Predicting the Responsiveness to an Anti-TNF Alpha Antibody Treatment
03/08/2012US20120058107 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
03/08/2012US20120058100 Modulation of drug release rate from electrospun fibers
03/08/2012US20120058098 Non-cytotoxic protein conjugates
03/08/2012US20120058093 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
03/08/2012US20120058089 Treatment of organ injuries and burns using placental stem cells
03/08/2012US20120058088 Resveratrol-Containing Compositions And Methods Of Use
03/08/2012US20120058087 Diagnosis of endometritis
03/08/2012US20120058082 Methods and compositions for treatment
03/08/2012US20120058055 Gastrorententive oral high dose zinc preparations
03/08/2012US20120056742 System for Image Analysis in a Network that is Structured with Multiple Layers and Differentially Weighted Neurons
03/08/2012CA2810202A1 Methods and compositions for delivering interleukin-1 receptor antagonist
03/08/2012CA2810071A1 Substituted tetrahydropyrrolopyrazine derivatives
03/08/2012CA2810024A1 Quinazoline compounds and methods of use thereof
03/08/2012CA2809991A1 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
03/08/2012CA2809493A1 Peptide or peptide complex binding to .alpha.2 integrin and methods and uses involving the same
03/08/2012CA2808237A1 High dose buprenorphine compositions and use as analgesic
03/07/2012EP2426139A1 CXCR4 antagonist and use thereof
03/07/2012EP2426134A2 Method of modulating stress-activated protein kinase system
03/07/2012EP2426132A1 Process for preparing 14-hydroxycodeinone from thebaine
03/07/2012EP2426122A1 Methylene urea derivative as RAF kinasse inhibitors
03/07/2012EP2426113A1 Carbinol compound having heterocyclic linker
1 ... 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 ... 1272